19.03.2020 Symrise AG  DE000SYM9999

DGAP-News: Symrise AG postpones Annual General Meeting 2020


 

DGAP-News: Symrise AG / Key word(s): AGM/EGM
Symrise AG postpones Annual General Meeting 2020

19.03.2020 / 14:44
The issuer is solely responsible for the content of this announcement.


Press release
-

Holzminden, 19 March 2020

Symrise postpones Annual General Meeting 2020

Annual General Meeting planned for 06 May 2020 in Holzminden postponed

Decision due to the progression of the corona pandemic
 


Symrise AG is postponing the Annual General Meeting that was originally scheduled for 06 May 2020 in Holzminden. This was decided by the Board of Management and the Supervisory Board today.

Against the background of the worldwide spread of the coronavirus (SARS-CoV-2) and based on a careful assessment of all aspects, in particular the health of all participants, Symrise AG has decided to postpone the event. The health of shareholders, employees as well as the service providers and guests is a top priority for the company. By refraining from holding major events, Symrise would like to make an active contribution to curbing the spread of the virus. In doing so, Symrise also complies with the decrees issued by the Ministry of Health of Lower Saxony on March 16 and 17.

Due to the cancellation of the original date of the Annual General Meeting, among other things, the resolution on the appropriation of the net profit for 2019 and the payment of the proposed dividend of 95 €-cents per share will be postponed.

Depending on the further course of the wave of infection and the measures ordered by the responsible authorities, Symrise AG will inform its shareholders and the public in a timely manner about the further planning. The new date will be announced in due course. The company's goal is to reschedule the event at the earliest possible time.

About Symrise:

Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food.

Its sales of approximately € 3.4 billion in the 2019 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America.

Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility
are inextricably linked as part of this process. Symrise - always inspiring more .

www.symrise.com

 

Media Contact: Investor Contact:
Bernhard Kott Tobias Erfurth
Phone: +49 (0)5531 90-1721 Phone: +49 (0)5531 90-1879
Email: [email protected] Email: [email protected]
   
Social media:  
twitter.com/symriseag linkedin.com/company/symrise
youtube.com/agsymrise xing.com/companies/symrise
instagram.com/symriseag  
 

 



19.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail: [email protected]
Internet: www.symrise.com
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1001857

 
End of News DGAP News Service

1001857  19.03.2020 

fncls.ssp?fn=show_t_gif&application_id=1001857&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.996,29 3.154,03 3.407,85 3.520,45 3.825,69 4.618,48 4.730,19
EBITDA1,2 630,31 630,52 685,07 742,08 813,62 795,42 851,65
EBITDA-Marge3 21,04 19,99 20,10 21,08 21,27 17,22
EBIT1,4 431,59 433,97 455,35 487,51 558,96 503,98 559,36
EBIT-Marge5 14,40 13,76 13,36 13,85 14,61 10,91 11,83
Jahresüberschuss1 275,65 297,69 297,88 314,95 385,03 290,70 344,94
Netto-Marge6 9,20 9,44 8,74 8,95 10,06 6,29 7,29
Cashflow1,7 396,18 441,79 546,76 635,68 521,56 360,11 719,51
Ergebnis je Aktie8 2,06 2,08 2,12 2,22 2,70 2,00 2,44
Dividende8 0,88 0,90 0,95 0,97 1,02 1,10 0,85
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ernst & Young

INVESTOR-INFORMATIONEN
©boersengefluester.de
Symrise
WKN Kurs in € Einschätzung Börsenwert in Mio. €
SYM999 102,700 Halten 14.354,59
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
30,21 38,34 0,79 45,87
KBV KCV KUV EV/EBITDA
4,13 19,95 3,03 19,99
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,10 1,10 1,07 15.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 01.08.2024 24.10.2024 06.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,87% 5,44% 3,07% -3,07%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Symrise AG  ISIN: DE000SYM9999 können Sie bei EQS abrufen


Chemie , SYM999 , SY1 , XETR:SY1